1-196779843-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6BP7
The NM_021023.6(CFHR3):āc.300T>Cā(p.Tyr100=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000163 in 1,532,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.000029 ( 0 hom., cov: 25)
Exomes š: 0.000015 ( 0 hom. )
Consequence
CFHR3
NM_021023.6 synonymous
NM_021023.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.26
Genes affected
CFHR3 (HGNC:16980): (complement factor H related 3) The protein encoded by this gene is a secreted protein, which belongs to the complement factor H-related protein family. It binds to heparin, and may be involved in complement regulation. Mutations in this gene are associated with decreased risk of age-related macular degeneration, and with an increased risk of atypical hemolytic-uremic syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 1-196779843-T-C is Benign according to our data. Variant chr1-196779843-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 3053010.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-4.26 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR3 | NM_021023.6 | c.300T>C | p.Tyr100= | synonymous_variant | 3/6 | ENST00000367425.9 | |
CFHR3 | NM_001166624.2 | c.300T>C | p.Tyr100= | synonymous_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR3 | ENST00000367425.9 | c.300T>C | p.Tyr100= | synonymous_variant | 3/6 | 1 | NM_021023.6 | P1 | |
CFHR3 | ENST00000471440.6 | c.300T>C | p.Tyr100= | synonymous_variant | 3/5 | 1 | |||
CFHR3 | ENST00000391985.7 | c.300T>C | p.Tyr100= | synonymous_variant | 3/5 | 2 | |||
CFHR3 | ENST00000367427.7 | c.300T>C | p.Tyr100= | synonymous_variant, NMD_transcript_variant | 3/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000291 AC: 4AN: 137356Hom.: 0 Cov.: 25
GnomAD3 genomes
AF:
AC:
4
AN:
137356
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000110 AC: 26AN: 236610Hom.: 0 AF XY: 0.0000941 AC XY: 12AN XY: 127516
GnomAD3 exomes
AF:
AC:
26
AN:
236610
Hom.:
AF XY:
AC XY:
12
AN XY:
127516
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000151 AC: 21AN: 1395140Hom.: 0 Cov.: 31 AF XY: 0.0000144 AC XY: 10AN XY: 692428
GnomAD4 exome
AF:
AC:
21
AN:
1395140
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
692428
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000291 AC: 4AN: 137356Hom.: 0 Cov.: 25 AF XY: 0.0000449 AC XY: 3AN XY: 66794
GnomAD4 genome
AF:
AC:
4
AN:
137356
Hom.:
Cov.:
25
AF XY:
AC XY:
3
AN XY:
66794
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CFHR3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 12, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at